Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :14968563
Publication Date : //

[Development of blood examination method of serum amyloid A and LDL complex, and clinical application to prediction of cardiovascular event].


In recent years, it has been reported that the acute-phase proteins C-reactive protein(CRP) and serum amyloid A(SAA), the sera levels of which are elevated in inflammation, are also elevated in coronary artery disease such as acute myocardial infarction. Also, high-sensitivity CRP assay is thought to be useful in predicting the prognosis of coronary heart disease. While investigating complexes of acute-phase proteins and low-density lipoprotein(LDL), we found a complex of LDL and SAA(SAA/LDL complex). The SAA/LDL complex in blood are formed from LDL and HDL by an oxidation reaction. Therefore, we developed an ELISA using anti-human SAA antibody and anti-human apoB, and determined a new method for measuring SAA/LDL complex in sera. We evaluated SAA/LDL complex as a new marker for prediction of prognosis in addition to the ordinary markers in consecutive 140 patients with stable coronary heart disease who had at least 1 coronary artery stenosis more than 50% in diameter at the diagnostic coronary angiography. Of these 140 patients, 2 developed fatal myocardial infarction, 2 cerebral infarction, and 17 angina pectoris requiring coronary revascularization therapy during 1 year and 6 months after blood examinations. The SAA/LDL complex value in this EVENT group of 21 patients was significantly higher than that in the control group of 119 individuals. High-sensitivity CRP (hs-CRP) assay and SAA measurement showed no significant difference between the 2 groups. The SAA/LDL complex reflects intravascular inflammation directly and can be a new marker more sensitive than hs-CRP or SAA for prediction of prognosis in patients with stable coronary artery disease.

Authors : Mashiba Shinichi , Ogasawara Ken , Takeya Motohiro , Wada Youichiro , Sahara Makoto , Kojima Shiho , Tabata Kazue , Ueda Masashi , Uchida Kazuo , Aizawa Tadanori , Kodama Tatsuhiko ,

Related products :

Catalog number Product name Quantity
Cardiovascular - CVD231 Cardiovascular disease tissue array, 23 cases of normal, reactive and neoplastic cardiovascular conditions. Designed for blood vessel or endothelial cell related studies. 2.5mm
Cardiovascular - CVD481 Cardiovascular disease tissue array, non_overlapping with CVD231, 24 cases of normal, reactive and neoplastic cardiovascular tissues in duplicates. Designed for blood vessel or endothelial cell relate 2mm
27-465 ZFP57 is a protein similar to zinc finger protein 57. It is derived from an annotated genomic sequence (NT_007592) using gene prediction method. 0.05 mg
29-191 ZFP57 is a protein similar to zinc finger protein 57. It is derived from an annotated genomic sequence (NT_007592) using gene prediction method. 0.1 mg
28-711 The amino acid sequence of 1110033M05Rik is derived from an annotated genomic sequence (NT_039589) using gene prediction method GNOMON, supported by mRNA and EST evidence. 0.05 mg
30-678 The amino acid sequence of hCG_1646157 is derived from an annotated genomic sequence (NT_024477) using gene prediction method GNOMON, supported by mRNA and EST evidence. The exact function of hCG_164 0.05 mg
26-571 The amino acid sequence of hCG_1646157 is derived from an annotated genomic sequence (NT_024477) using gene prediction method GNOMON, supported by mRNA and EST evidence. The exact function of hCG_164 0.05 mg
30-696 The sequence of LOC442049 is derived from an annotated genomic sequence (NW_921562) using gene prediction method GNOMON. The exact function of LOC442049 remains unknown. 0.05 mg
30-520 The sequence of LOC652559 is derived from an annotated genomic sequence (NW_922352) using gene prediction method GNOMON. The exact function of LOC652559 remains unknown. 0.05 mg
30-700 The sequence of LOC641765 is derived from an annotated genomic sequence (NT_079593) using gene prediction method GNOMON, supported by EST evidence. The exact function of LOC641765 remains unknown. 0.05 mg
30-519 The sequence of LOC650515 is derived from an annotated genomic sequence (NW_922073) using gene prediction method GNOMON, supported by EST evidence. The exact function of LOC650515 remains unknown. 0.05 mg
1735 Cardiovascular disease tissue array, including TNM and clinical stage, 24 cases_48 cores
1741 Cardiovascular disease tissue array, including TNM and clinical stage, 24 cases_24 cores
401-4S Blood grouping Kit (Anti-A, B, AB, D) Method: Slide, tube _ agglutinating Blood Grouping Reagents 4x10 ml
BE-20 Endotoxin Assay Kit (Kinetic-Turbidimetric method, clinical diagnosis for human) 20 tests/kit
TA506 Bilirubin Direct (DMSO Method), 4x125ml, Clinical Chemistry Kits 5
TA503 Bilirubin Total (DMSO Method), 2x125ml, Clinical Chemistry Kits 10
TA504 Bilirubin Total (DMSO Method), 4x125ml, Clinical Chemistry Kits 5
TA505 Bilirubin Direct (DMSO Method), 2x125ml, Clinical Chemistry Kits 10
TA507 Bilirubin Total & Direct (DMSO Method), 2x125ml, Clinical Chemistry Kits 10
TA520 HDL Choelsterol, Enzymatic Colorimetric Direct Method, 100 Tests, Clinical Chemistry Kits
TA508 Bilirubin Total & Direct (DMSO Method), 4x125ml, Clinical Chemistry Kits 5
TA521 LDL Cholesterol, Enzymatic Colorimetric Direct Method, 100 Tests, Clinical Chemistry Kits
B437 Brain Heart Infusion w_PABA USE For examination of blood from patients under sulphonamide therapy. Qty per Litre of Medium: 37
B437 Brain Heart Infusion w_PABA USE : For examination of blood from patients under sulphonamide therapy. 5x500gm


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur